Literature DB >> 3623000

Developmental regulation of sialic acid modifications in rat and human colon.

E A Muchmore, N M Varki, M Fukuda, A Varki.   

Abstract

Using high-pressure liquid chromatography (HPLC) and gas-liquid chromatography/mass spectrometry (GLC/MS), we have confirmed the existence of several sialic acid modifications in the adult rat and human colon. The major O-acetylated sialic acid in both species is 9-O-acetyl-N-acetylneuraminic acid; N-glycolylneuraminic acid is a major component of the adult rat colon. Both of these major modifications were found to be developmentally regulated during the perinatal period in the rat. The N-glycolyl modification is present prenatally and disappears rapidly in the postnatal period. It reappears in the preweanling period, reaching levels at weaning comparable to those found prenatally. In contrast, the 9-O-acetyl modification is very low prenatally, and undergoes a marked increase shortly after birth in both the rat and human colon. The difference in the kinetics of appearance of the two modifications suggests that they are independently regulated. Regulation of these modifications seems to be influenced by exposure to bacterial by-products or environmental stimuli. The N-glycolyl modification in the rat colon reappeared at weaning, a time of major change in enteral colonic substances. Spontaneously aborted human fetuses, including three with intrauterine infection at 27, 33, and 35 wk of gestation, showed adult levels of O-acetylation in colonic tissue. Also, although O-acetylation in freshly isolated colon tumor specimens was only somewhat lower than that in the adult normal colon, all established colon cancer cell lines studied showed minimal O-acetylation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3623000     DOI: 10.1096/fasebj.1.3.3623000

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  13 in total

Review 1.  Perspectives on the significance of altered glycosylation of glycoproteins in cancer.

Authors:  Y J Kim; A Varki
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

2.  Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats.

Authors:  Leslie A Khawli; Sirj Goswami; Ryan Hutchinson; Zephania W Kwong; Jihong Yang; Xiangdan Wang; Zhenling Yao; Alavattam Sreedhara; Tony Cano; Devin Tesar; Ihsan Nijem; David E Allison; Pin Yee Wong; Yung-Hsiang Kao; Cynthia Quan; Amita Joshi; Reed J Harris; Paul Motchnik
Journal:  MAbs       Date:  2010-11-01       Impact factor: 5.857

3.  9-O-Acetylation of sialomucins: a novel marker of murine CD4 T cells that is regulated during maturation and activation.

Authors:  M Krishna; A Varki
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

4.  Detection of CMP-N-acetylneuraminic acid hydroxylase activity in fractionated mouse liver.

Authors:  L Shaw; R Schauer
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

5.  Indications for the enzymatic synthesis of 9-O-lactoyl-N-acetylneuraminic acid in equine liver.

Authors:  R G Kleineidam; O Hofmann; G Reuter; R Schauer
Journal:  Glycoconj J       Date:  1993-02       Impact factor: 2.916

6.  9-O-acetylated sialic acids have widespread but selective expression: analysis using a chimeric dual-function probe derived from influenza C hemagglutinin-esterase.

Authors:  A Klein; M Krishna; N M Varki; A Varki
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

7.  A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence.

Authors:  H H Chou; H Takematsu; S Diaz; J Iber; E Nickerson; K L Wright; E A Muchmore; D L Nelson; S T Warren; A Varki
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

8.  Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution.

Authors:  Hsun-Hua Chou; Toshiyuki Hayakawa; Sandra Diaz; Matthias Krings; Etty Indriati; Meave Leakey; Svante Paabo; Yoko Satta; Naoyuki Takahata; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

Review 9.  The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human.

Authors:  Anthony P Corfield
Journal:  Microorganisms       Date:  2018-08-02

10.  Modified Sialic Acids on Mucus and Erythrocytes Inhibit Influenza A Virus Hemagglutinin and Neuraminidase Functions.

Authors:  Karen N Barnard; Brynn K Alford-Lawrence; David W Buchholz; Brian R Wasik; Justin R LaClair; Hai Yu; Rebekah Honce; Stefan Ruhl; Petar Pajic; Erin K Daugherity; Xi Chen; Stacey L Schultz-Cherry; Hector C Aguilar; Ajit Varki; Colin R Parrish
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.